Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis Pigmentosa
Investigative Ophthalmology & Visual Science · 2026-03-02 · 67 (3) · 2
DOI: 10.1167/iovs.67.3.2 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, published on 2026-03-02. Written by Emmanuelle Clérin and 16 co-authors. Institution: Department of Genetics, Sorbonne Université, CNRS, INSERM, Institut de la Vision, Paris, France. Major MEDLINE topics: Retinitis Pigmentosa, Dependovirus, Genetic Therapy, Eye Proteins. Cited 2 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Retinitis pigmentosa (RP) is an inherited retinal degeneration that progresses from rod to cone degeneration. Several gene-independent adeno-associated virus (AAV)-based strategies have revealed a partial restauration of RP using AAV vectors coding for either rod-derived cone viability factor (RdCVF) or its long form (RdCVFL). The nucleoredoxin-like 1 gene (NXNL1) encodes two proteins, the short isoform RdCVF and the long isoform (RdCVFL). RdCVF acts by stimulating aerobic glycolysis to sustain cone outer segment renewal, and RdCVFL is thought to modulate oxidative stress. In prior studies, we analyzed the structural and functional effect of each isoform delivered independently through co-injection of two vectors carrying each. Here, we aimed to maintain visual function by performing a unilateral subretinal injection of a single AAV vector encoding both human isoforms, hRdCVF and hRdCVFL, in an RP mouse model.
Methods
The therapeutic effect of AAV-hRdCVF/hRdCVFL versus AAV-hRdCVF was evaluated using a visual function test on rd10 mice followed by automated cone counting and measurement of lipid peroxidation.
Results
A significant visual preservation using AAV-hRdCVF/hRdCVFL versus AAV-hRdCVF was observed from 28 days post-injection, as shown by delayed visual loss, increased cone density, and reduced lipid peroxidation.
Conclusions
This study revealed that both proteins encoded by NXNL1 are essential for gene-independent RP treatment and that combining RdCVF and RdCVFL delivery with a single AAV vector yields a more substantial photoreceptor-protective effect. This functional proof of concept supports the ongoing gene therapy phase 1/2 trial Promising ROd-cone DYstrophy Gene therapY (PRODYGY, NCT05748873).
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Genetics, Sorbonne Université, CNRS, INSERM, Institut de la Vision, Paris, France.
- Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.
- Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
- Centre Hospitalier National d'Ophtalmologie des 15-20, Centre de Référence Maladies Rares REFERET and INSERM-DGOS (CIC 1423), Paris, France.
Cite
APA
Clérin, E., Yang, Y., Pagan, D., Achiedo, S., Blond, F., Millet-Puel, G., Aït-Ali, N., Harichane, I., Dégardin, J., César, Q., Simonutti, M., Bennett, J., Zeitz, C., Audo, I., Cronin, T., Léveillard, T., & Sahel, J. A. (2026). Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science, 67(3), 2. https://doi.org/10.1167/iovs.67.3.2
Vancouver
Clérin E, Yang Y, Pagan D, Achiedo S, Blond F, Millet-Puel G, et al. Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. 2026;67(3):2. doi:10.1167/iovs.67.3.2
BibTeX
@article{Clrin2026,
author = {Clérin, Emmanuelle and Yang, Ying and Pagan, Delphine and Achiedo, Seiki and Blond, Frédéric and Millet-Puel, Géraldine and Aït-Ali, Najate and Harichane, Imen and Dégardin, Julie and César, Quenol and Simonutti, Manuel and Bennett, Jean and Zeitz, Christina and Audo, Isabelle and Cronin, Thérèse and Léveillard, Thierry and Sahel, José-Alain},
title = {Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis Pigmentosa},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
volume = {67},
number = {3},
pages = {2},
doi = {10.1167/iovs.67.3.2}
}
EUVIMED